Login to Your Account


Biokangtai’s HBV vaccine cleared of links to 17 dead children, back on market

By Cornelia Zou
Staff Writer

Wednesday, January 29, 2014

HONG KONG – China’s largest producer of hepatitis B vaccine (HBV) was allowed to put its products back on market after the China Food and Drug Administration (CFDA) cleared it of any links to the deaths of 17 children.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription